Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 10.375 GBX -0.24% Market Closed
Market Cap: 42.8m GBX

Wall Street
Price Targets

CREO Price Targets Summary
Creo Medical Group PLC

Wall Street analysts forecast CREO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CREO is 40.8 GBX with a low forecast of 40.4 GBX and a high forecast of 42 GBX.

Lowest
Price Target
40.4 GBX
289% Upside
Average
Price Target
40.8 GBX
293% Upside
Highest
Price Target
42 GBX
305% Upside
Creo Medical Group PLC Competitors:
Price Targets
688617
APT Medical Inc
62% Upside
IRMD
IRadimed Corp
4% Upside
CLPT
Clearpoint Neuro Inc
120% Upside
NVST
Envista Holdings Corp
10% Upside
1302
LifeTech Scientific Corp
5% Upside
BDX
Becton Dickinson and Co
10% Upside

Revenue
Forecast

Revenue Estimate
Creo Medical Group PLC

The compound annual growth rate of Creo Medical Group PLC's revenue for the next 3 years is 65%.

N/A
Past Growth
65%
Estimated Growth
Estimates Accuracy
-44%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Creo Medical Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat

Net Income
Forecast

Net Income Estimate
Creo Medical Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CREO's stock price target?
Price Target
40.8 GBX

According to Wall Street analysts, the average 1-year price target for CREO is 40.8 GBX with a low forecast of 40.4 GBX and a high forecast of 42 GBX.

What is Creo Medical Group PLC's Revenue forecast?
Projected CAGR
65%

The compound annual growth rate of Creo Medical Group PLC's revenue for the next 3 years is 65%.

Back to Top